Method for enhancing endothelial function in humans
First Claim
1. A method for enhancing the endothelial function in humans, comprising administering to the person an NPY receptor active agent, wherein said receptor is present in the endothelial tissue.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention concerns a method for enhancing the endothelial function in humans, comprising administering to the person an NPY receptor active agent, wherein said receptor is present in the endothelial tissue. Furthermore, the invention concerns methods for the treatment or prevention of atherosclerotic vascular diseases; vascular spasm associated with angina pectoris; micro- or macrovascular complications of diabetes; premature ejaculation and impotence; or any disease or disorder where a deficit in the formation of nitric oxide for the vascular endothelium appears evident, said methods comprising administering to the person an NPY receptor active agent, wherein said receptor is present in the endothelial tissue.
-
Citations
24 Claims
- 1. A method for enhancing the endothelial function in humans, comprising administering to the person an NPY receptor active agent, wherein said receptor is present in the endothelial tissue.
- 5. A method for the treatment or prevention of atherosclerotic vascular diseases, comprising administering to the person an NPY receptor active agent, wherein said receptor is present in the endothelial tissue.
- 9. A method for the treatment or prevention of vascular spasm associated with angina pectoris, comprising administering to the person an NPY receptor active agent, wherein said receptor is present in the endothelial tissue.
- 13. A method for the treatment or prevention of micro- or macrovascular complications of diabetes, comprising administering to the person an NPY receptor active agent, wherein said receptor is present in the endothelial tissue.
- 17. A method for the treatment or prevention of any disease or disorder where a deficit in the formation of nitric oxide for the vascular endothelium appears evident, said method comprising administering to the person an NPY receptor active agent, wherein said receptor is present in the endothelial tissue.
- 21. A method for the treatment or prevention of premature ejaculation and impotence, said method comprising administering to the person an NPY receptor active agent, wherein said receptor is present in the endothelial tissue.
Specification